Peptomyc
New generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment
Peptomyc has raised €17M across 3 funding rounds from 8 investors, most recently a round in Apr 2026. Based in Barcelona, Spain; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€17M
€17,400,000
Funding rounds
3
Investors
8
distinct backers
Active since
2016-05
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDPeptomyc — funding by year — interactive chart.
Data table
| Peptomyc — funding by year | |
|---|---|
| 2016 | €1.0M |
| 2020 | €11M |
| 2026 | €5.0M |
Signals
High confidenceRaise-next likelihood23
base rate 30% for Other
- ▼ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood17
base rate 11% (2+ rounds)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-09 | Other | €5.0M | Alta Life Sciences,Aurora Science,CDTI Innovación,EIC Fund,Existing investors,Laudecum+1 more | View deal → |
| 2020-12-16 | Other | €11M | Aurora Science | View deal → |
| 2016-05-01 | Seed | €1.0M | Riva y Garcia Private Equity | View deal → |
Investors
8Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData